Mpox: Are We Letting Our Guard Down Too Soon? Experts Sound the Alarm!
The fight against mpox in Nigeria is far from over, despite what recent positive trends might suggest. That's the stark warning from former Minister of Health, Prof. Isaac Adewole, and a chorus of leading public health voices. They're urging us to recognize that mpox is still actively circulating within the country. Improved surveillance and case management are encouraging, but they're not a victory in themselves.
Prof. Richard Adegbola, Dr. Sebestine Oiwoh, and Victor Erunkunakpor are among the concerned experts who agree that mpox remains a significant public health challenge, both nationally and globally. Their shared experience on the front lines, both in clinics and within communities, paints a clear picture: complacency could allow mpox to become permanently embedded in Nigeria. This isn't just about numbers; it's about preventing a future where mpox is a constant threat.
Prof. Adewole emphasized the unpredictable nature of infectious diseases in Nigeria during a recent webinar on mpox. "When we have an outbreak, it gets complicated and then settles down. That is frightening," he stated, highlighting the dangerous lull that can occur before a resurgence. He cited a recent conversation with the Director-General of the NCDC, who was managing seven active outbreaks simultaneously. Adewole fears that mpox could become "a native of Nigeria" if swift action isn't taken – a fate already suffered by Lassa fever, which has transitioned from a seasonal threat to a year-round concern. But here's where it gets controversial... Some researchers argue that completely eradicating a disease like mpox, particularly when it has animal reservoirs, is unrealistic. Is containment and management a more achievable and sustainable goal?
Victor Erunkunakpor echoed the urgency, focusing on practical steps to prevent mpox from becoming endemic. He pointed out that mild cases often go unnoticed, allowing the virus to spread silently. "We need to scale up vaccination, particularly for health workers, and classify those at heightened risk to protect them," he urged. This includes not only healthcare professionals but also individuals with compromised immune systems and those who may have had close contact with confirmed cases. Erunkunakpor emphasized: "Investment in vaccination, surveillance, and community education is our best defense." Think of it like building a three-layered shield: vaccination provides individual protection, surveillance helps detect outbreaks early, and education empowers communities to take preventative measures.
Prof. Richard Adegbola stressed that managing mpox, like any infectious disease, requires a holistic approach encompassing clinical care, community engagement, and accurate public awareness. And this is the part most people miss: the psychological and social impact of the disease. Stigma, he explained, often stems from misinformation at the community level. "If people don’t understand the disease, the actions that follow perception are where stigma comes in," Adegbola noted. Imagine the fear and discrimination someone might face if their community believes mpox is caused by witchcraft or is a sign of moral failing. He passionately advocated for continued investment in laboratory capacity and community education to ensure accurate information reaches every corner of the country. This means training healthcare workers, distributing informative materials, and engaging community leaders to dispel myths and promote understanding.
Dr. Sebastine Oiwoh, a dermatologist, highlighted the importance of home-based care protocols for managing uncomplicated cases. However, he stressed that operational factors, such as housing conditions and access to healthcare workers, are critical for safe and effective home management. Not everyone has the space or resources to isolate properly, making hospital escalation necessary in some cases. Oiwoh also emphasized the risks of ocular involvement, noting that lesions affecting the eye require immediate hospital intervention to prevent blindness. This underscores the need for clear guidelines and accessible healthcare for all patients.
Oiwoh's experience also showcases the power of digital health technologies. Tele-dermatology and digital reporting systems have enabled him to monitor outbreaks, guide sampling for laboratory testing, and support genomic sequencing. This is particularly valuable in remote areas with limited access to specialized healthcare. He called for expanded community engagement and public health education to counter misinformation and stigma, noting that survivors can play a crucial role in promoting awareness and confidence in vaccination. Imagine the impact of hearing a survivor share their personal experience and encourage others to get vaccinated! What role do you think social media should play in disseminating accurate information about mpox, and what strategies can be used to combat the spread of misinformation online? Do you agree with the experts' call for increased vaccination, even if the risk of contracting mpox seems low in your community? Share your thoughts and concerns in the comments below.
